Background: Sub-acromial impingement syndrome (SAIS) is the most common disorder of shoulder. Conservative treatment is the first choice, often with corticosteroid injection or different physiotherapy interventions, or both. So we aimed to assess the mean reduction in shoulder pain and disability index (SPADI) score after administration of sub-acromial corticosteroid injections for management of SAIS. Objectives: To determine the mean reduction in SPA-DI score after administration of Sub-acromial cortico-
Introduction
Sub-acromial impingement syndrome (SAIS) accounts for 44 -65% of shoulder pain and is the most common disorder of shoulder.
1 SAIS represents spectrum of disease process that ranges from sub-acromial bursitis to rotator cuff tendinopathy and full thickness tears. 2 
Original Article
Functional loss and disability are the major consequences of SAIS.
1 This is associated with substantial impact daily activities and on sleeping. 3 The pathogenesis of rotator cuff degeneration is unknown. Theories for pathogenesis are extrinsic cause i.e. compression of the rotator cuff and intrinsic cause i.e. tendon degeneration.
It is diagnosed clinically based on history and clinical signs as Neer impingement sign and HawkinsKennedy impingement sign. Imaging is helpful adjunct for confirming the diagnosis. MRI is the most helpful technique in evaluating shoulder pain secondary to sub-acromial impingement and rotator cuff disease. 4 Conservative management with corticosteroid injection and/or physiotherapy is the first choice for SAIS. 5 Nonsurgical treatment is successful in most patients with SAIS. Surgical intervention is successful in patients in whom nonsurgical treatment fails. 1, 6 Mechanism of action of local steroid injection is not well known. Most likely mechanisms include antiinflammatory effects, influence of local tissue metabolism, pain relief, mechanical improvement, relief of reflex muscle spasm and placebo effect. 7 Rationale of this study was to determine the mean reduction in SPADI score after administration of subacromial corticosteroid injections for management of SAIS because of unavailability of expertise in our country and absence of local study.
Patient and Methodology
150 patients presenting to outdoor of Mayo hospital with age greater than 18 years and positive for signs of shoulder impingement syndrome on clinical examination (like Neer impingement test, Hawkins -Kennedy impingement sign, Jobes supraspinatus test) were involved in this study. All the patient with history of shoulder fracture or fracture in the shoulder joint and those with pain referring from cervical spine and those with inflammatory arthritis were excluded from the study. Baseline SPADI score was noted. Patients were injected with sub acromial injections of 40 mg triamcinolone acetonide mixed with 4.5 ml of 2% lignocaine under aseptic measures. The needle was angled approximately 45° cephalad to follow the contour of posterior acromion. After injection patients were advised to refrain from heavy arm activities for next 2 weeks. All patients underwent physiotherapy consisting of pendulum and range of motion under care of physiotherapist. Each patient was followed-up in OPD for assessment of shoulder function according to SPADI score at 1, 3 and 6 weeks after administration of injection. Mean of these 3 readings were calculated and subtracted from baseline SPADI score. The data analysis was entered and analyzed by using SPSS version 16.
Results
Total 150 patients were enrolled in this study. The mean age of the patients was noted as 44.58 ± 11.48 years (range 25 -70 years). 46.67% patients were males whereas 53.33% patients were females. The mean SPADI score of the patients at baseline was noted as 75.94 ± 7.73 (ranges 60.76 -89.23) No drop out was found.
The mean SPADI score of the patients at week 1 was noted as 62.50 ± 7.58 (ranges 52.30 -75.38).
The mean SPADI score of the patients at week 3 was noted as 52.58 ± 5.93 (ranges 44.16 and 61.53).
The mean SPADI score at week 6 of the patients was noted as 46.25 ± 5.62 with minimum and maximum values of 36.92 and 56.15 respectively.
In this study the mean SPADI reduction of the patients was noted as 22.15 ± 3.93 with minimum and maximum values of 14.35 and 30.77 respectively. Statistically significant difference was found between the pre SPADI score values comparison with post values at week 1, week 3 and Week 6 respectively. i.e. p-value = 0.000,0.000,0.000.
Discussion
The shoulder impingement syndrome leads to painful shoulder joint along with range of motion limitation and reduction in quality of life. Thirty to 80% of subacromial injections reaches the sub-acromial bursa or the sub-acromial space when placed blindly. 8 Our study results showed that the mean SPADI score at baseline was 75.94 ± 7.73 and it reduced to 22.15 ± 3.93 after the administration of injection. One previous study reported that in patients with sub-acromial impingement syndrome, the baseline mean SPA-DI score was 46.25 ± 7.86 which was reduced to 32.01 ± 6.76 after 6 weeks of administration of sub-acromial corticosteroid injections. 9 Our study results showed statistically significance difference between the baseline SPADI score values and follow-up values after administration of sub-acromial corticosteroid injections for management of subacromial impingement syndrome. Many of studies support the results in favor of our study. There are studies that reports good short term improvement after accurate placement of injection in the sub-acromial bursa. 8, 10 In study by Niamh Hambly et al they concluded that sub-acromial steroid is helpful for short -term management of clinically and magnetic resonance imaging proven SAIS. Here 83% patients had relief on 6 th month follow-up. It was found that better outcome is in those who have shorter duration of symptoms and minor changes in MRI. 4 OM Ekeberg et al, found that the mean difference in SPADI from baseline to the 6 week follow-up was 24.4 for those receiving sub-acromial steroid injection and 19.2 for those receiving systemic corticosteroid. The results at 6 week follow-up favored the group having local injections. 7 In one study it was seen that only 29% of blindly administered sub-acromial injections are accurately placed. 11 In a study by Chard et al., 39.4% of conservatively treated patients reports relief from symptoms at follow-up. 12 Ali Yeganeh et al, demonstrated in their study that sub-acromial corticosteroid injection results in improvement in the symptoms but long-term results were in favor of physiotherapy. This favors conservative treatment before surgery in patient with sub-acromial impingement syndrome. 6 Ludewig and Borstad studied the result after home -based physiotherapy for 10 weeks. They established significant improvements in work -related pain and disability, and the shoulder rating questionnaire in the exercise group (n = 34) after 10 weeks when compared to a control group (n = 33) receiving no treatment. 12 Naredo et al and Chen et al, reports ultrasound guided sub-acromial steroid injection to be better than blind injection in SAIS. 13 Inconclusive results are there regarding the use of local steroid injection in sub-acromial impingement syndrome. Winters et al. categorized patients with shoulder pain clinically into a shoulder girdle and a synovial group. Manipulation is the best treatment for shoulder girdle group, whereas corticosteroid injection is best for synovial group.
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Conclusion
Our study results concluded that sub-acromial corticosteroid injection is an effective drug used for the management of sub-acromial impingement syndrome. However its long term effect needs further follow-up.
